国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Streptococcus pneumoniae Serine hydroxymethyltransferase (glyA) CSB-YP814876SMP
CSB-EP814876SMP
CSB-BP814876SMP
CSB-MP814876SMP
CSB-EP814876SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Bifunctional protein GlmU (glmU) CSB-YP814877SMP
CSB-EP814877SMP
CSB-BP814877SMP
CSB-MP814877SMP
CSB-EP814877SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae UPF0346 protein spr0848 (spr0848) CSB-YP814878SMP
CSB-EP814878SMP
CSB-BP814878SMP
CSB-MP814878SMP
CSB-EP814878SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Putative agmatine deiminase (aguA) CSB-YP814879SMP
CSB-EP814879SMP
CSB-BP814879SMP
CSB-MP814879SMP
CSB-EP814879SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Probable dihydroorotate dehydrogenase A (fumarate) (pyrDA) CSB-YP814880SMP
CSB-EP814880SMP
CSB-BP814880SMP
CSB-MP814880SMP
CSB-EP814880SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Thiamine-phosphate synthase 1 (thiE1) CSB-YP814881SMP
CSB-EP814881SMP
CSB-BP814881SMP
CSB-MP814881SMP
CSB-EP814881SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Ribonuclease Z (rnz) CSB-YP814882SMP
CSB-EP814882SMP
CSB-BP814882SMP
CSB-MP814882SMP
CSB-EP814882SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Phenylalanine--tRNA ligase beta subunit (pheT), partial CSB-YP814883SMP
CSB-EP814883SMP
CSB-BP814883SMP
CSB-MP814883SMP
CSB-EP814883SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Putative ABC transporter ATP-binding protein spr0430 (spr0430), partial CSB-YP814884SMP
CSB-EP814884SMP
CSB-BP814884SMP
CSB-MP814884SMP
CSB-EP814884SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Trigger factor (tig) CSB-YP814885SMP
CSB-EP814885SMP
CSB-BP814885SMP
CSB-MP814885SMP
CSB-EP814885SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Endo-alpha-N-acetylgalactosaminidase (spr0328), partial CSB-YP814886SMP
CSB-EP814886SMP
CSB-BP814886SMP
CSB-MP814886SMP
CSB-EP814886SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Leucine--tRNA ligase (leuS), partial CSB-YP814887SMP
CSB-EP814887SMP
CSB-BP814887SMP
CSB-MP814887SMP
CSB-EP814887SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Methionine import ATP-binding protein MetN (metN) CSB-YP814888SMP
CSB-EP814888SMP
CSB-BP814888SMP
CSB-MP814888SMP
CSB-EP814888SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pneumoniae Peptidyl-tRNA hydrolase (pth) CSB-YP814889SMP
CSB-EP814889SMP
CSB-BP814889SMP
CSB-MP814889SMP
CSB-EP814889SMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Energy-coupling factor transporter ATP-binding protein EcfA 2 (ecfA2) CSB-YP814890FMR
CSB-EP814890FMR
CSB-BP814890FMR
CSB-MP814890FMR
CSB-EP814890FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arginine--tRNA ligase (argS), partial CSB-YP814891FMR
CSB-EP814891FMR
CSB-BP814891FMR
CSB-MP814891FMR
CSB-EP814891FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ribosomal protein L11 methyltransferase (prmA) CSB-YP814892FMR
CSB-EP814892FMR
CSB-BP814892FMR
CSB-MP814892FMR
CSB-EP814892FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 50S ribosomal protein L16 (rplP) CSB-YP814893FMR
CSB-EP814893FMR
CSB-BP814893FMR
CSB-MP814893FMR
CSB-EP814893FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 30S ribosomal protein S8 (rpsH) CSB-YP814894FMR
CSB-EP814894FMR
CSB-BP814894FMR
CSB-MP814894FMR
CSB-EP814894FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP814895FMR
CSB-EP814895FMR
CSB-BP814895FMR
CSB-MP814895FMR
CSB-EP814895FMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>